- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 237/00 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
Patent holdings for IPC class C07C 237/00
Total number of patents in this class: 101
10-year publication summary
1
|
2
|
3
|
5
|
2
|
3
|
0
|
4
|
2
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Takeda Pharmaceuticals U.S.A., Inc. | 187 |
6 |
Takeda Pharmaceutical Company Limited | 2703 |
4 |
Abbvie Inc. | 1793 |
3 |
Les Laboratoires Servier | 538 |
3 |
MPC Merger Sub, Inc. | 12 |
3 |
MPC Oldco, Inc. | 11 |
3 |
Calico Life Sciences LLC | 94 |
3 |
BASF SE | 20694 |
2 |
Pfizer Inc. | 3355 |
2 |
Massachusetts Institute of Technology | 9975 |
2 |
Aerie Pharmaceuticals, Inc. | 58 |
2 |
E. R. Squibb & Sons, L.L.C. | 120 |
2 |
Mutual Pharmaceutical Company, Inc. | 25 |
2 |
The University of North Carolina at Chapel Hill | 2022 |
2 |
Bristol-myers Squibb Company | 4897 |
1 |
Boehringer Ingelheim International GmbH | 4705 |
1 |
Allergan, Inc. | 2363 |
1 |
Merck Sharp & Dohme Limited | 57 |
1 |
Samsung SDI Co., Ltd. | 7894 |
1 |
Commissariat à l'énergie atomique et aux energies alternatives | 10787 |
1 |
Other owners | 56 |